Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Mariette

Showing results (11-20 of 593) with videos related to

Pageof 60
Sort By:
Annals of the Rheumatic Diseases|November 3, 2023
Long COVID: a new word for naming fibromyalgia?Xavier Mariette
Joint Bone Spine|October 12, 2004
The B cell: a new therapeutic target in rheumatoid arthritis and other autoimmune diseasesXavier Mariette
Immunotherapy|September 8, 2017
Certolizumab, an anti-TNF safe during pregancy? The CRIB Study results: an interview with Professor Xavier MarietteXavier Mariette
Annales De Medecine Interne|August 12, 2003
[Pathophysiology of Sjögren's syndrome]Xavier Mariette
Joint Bone Spine|September 3, 2003
Hepatitis C virus, arthritides, and arthromyalgiaXavier Mariette
Leukemia & Lymphoma|September 14, 2004
The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expressionSophie Roux, Xavier Mariette
Nature Reviews. Rheumatology|July 17, 2013
Advances in understanding the pathogenesis of primary Sjögren's syndromeGaëtane Nocturne, Xavier Mariette
Nature Reviews. Nephrology|November 17, 2015
Renal involvement in primary Sjögren syndromeHélène François, Xavier Mariette
Annals of the Rheumatic Diseases|September 21, 2017
The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapyLeonard Calabrese, Xavier Mariette
Rheumatic Diseases Clinics of North America|November 29, 2016
Malignancy and the Risks of Biologic Therapies: Current StatusRaphaèle Seror, Xavier Mariette
Pageof 60

Showing results (11-20 of 593) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|November 3, 2023
Long COVID: a new word for naming fibromyalgia?Xavier Mariette
Joint Bone Spine|October 12, 2004
The B cell: a new therapeutic target in rheumatoid arthritis and other autoimmune diseasesXavier Mariette
Immunotherapy|September 8, 2017
Certolizumab, an anti-TNF safe during pregancy? The CRIB Study results: an interview with Professor Xavier MarietteXavier Mariette
Annales De Medecine Interne|August 12, 2003
[Pathophysiology of Sjögren's syndrome]Xavier Mariette
Joint Bone Spine|September 3, 2003
Hepatitis C virus, arthritides, and arthromyalgiaXavier Mariette
Leukemia & Lymphoma|September 14, 2004
The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expressionSophie Roux, Xavier Mariette
Nature Reviews. Rheumatology|July 17, 2013
Advances in understanding the pathogenesis of primary Sjögren's syndromeGaëtane Nocturne, Xavier Mariette
Nature Reviews. Nephrology|November 17, 2015
Renal involvement in primary Sjögren syndromeHélène François, Xavier Mariette
Annals of the Rheumatic Diseases|September 21, 2017
The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapyLeonard Calabrese, Xavier Mariette
Rheumatic Diseases Clinics of North America|November 29, 2016
Malignancy and the Risks of Biologic Therapies: Current StatusRaphaèle Seror, Xavier Mariette
Pageof 60